I doubt PYC will talk about Plan Bs until Janssen clarifies its position.
Otherwise PYC might be seen as attempting to publicly "wedge" Jannsen.
This wouldn't be a good look.
As partners/collaborators the two groups need to ensure that their harmonic research relationship is not compromised by insensitive PR behavior.
janssen ponders phylogica peptide options , page-14
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.3¢ |
Change
-0.003(2.38%) |
Mkt cap ! $461.9M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.8¢ | $492.8K | 4.905M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 359228 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 839447 | 7 |
View Market Depth
| Last trade - 15.56pm 29/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |